US Patent 10399976 Dihydropyrrolopyridine inhibitors of ROR-gamma
Patent 10399976 was granted and assigned to Vitae Pharmaceuticals on September, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 2, 2018
Date of Patent
September 3, 2019
Patent Applicant
Patent Application Number
16025155
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10399976 Dihydropyrrolopyridine inhibitors of ROR-gamma
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.